Carisoprodol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Carisoprodol.
| Product ID | 0591-5513_47645d9b-8a05-4adf-979d-78791eac4da9 |
| NDC | 0591-5513 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Carisoprodol |
| Generic Name | Carisoprodol |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1987-11-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA087499 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | CARISOPRODOL |
| Active Ingredient Strength | 350 mg/1 |
| Pharm Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1987-11-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA087499 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1987-11-01 |
| Marketing Category | ANDA |
| Application Number | ANDA087499 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1987-11-01 |
| Marketing Category | ANDA |
| Application Number | ANDA087499 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-06-20 |
| Marketing End Date | 2012-06-12 |
| Marketing Category | ANDA |
| Application Number | ANDA087499 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1987-11-01 |
| Ingredient | Strength |
|---|---|
| CARISOPRODOL | 350 mg/1 |
| SPL SET ID: | ad627894-4d1e-4dae-8421-9aa1ce9a0208 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |